date,title,source
Oct-17-18,"The Daily Biotech Pulse: Eiger's Lymphoedema Drug Study Fails, Roche's Sales Rise",Benzinga
Oct-17-18,"ArQule to Report Third Quarter 2018 Financial Results on October 31, 2018",Business Wire
Oct-19-18,"New Research Coverage Highlights TIER REIT, Meridian Bioscience, ArQule, Greenlight Capital Re, ADT, and Turquoise Hill Resources  Consolidated Revenues, Company Growth, and Expectations for 2018",GlobeNewswire
Oct-19-18,"ArQule Presents Orphan Disease Clinical Data at the American Society of Human Genetics (ASHG) 2018 Annual Meeting for Its pan-AKT Inhibitor, Miransertib (ARQ 092)",Business Wire
Oct-31-18,Edited Transcript of ARQL earnings conference call or presentation 31-Oct-18 1:00pm GMT,Thomson Reuters StreetEvents
Oct-31-18,"ArQule (ARQL) Reports Q3 Loss, Tops Revenue Estimates",Zacks
Oct-31-18,ArQule: 3Q Earnings Snapshot,Associated Press
Oct-31-18,ArQule Reports Third Quarter 2018 Financial Results,Business Wire
Nov-01-18,ArQule (ARQL) Q3 2018 Earnings Conference Call Transcript,Motley Fool
Nov-08-18,ArQule to Present Clinical and Preclinical Data for ARQ 751 at the 30th EORTC/AACR/NCI Symposium,Business Wire
Nov-09-18,Edited Transcript of ARQL earnings conference call or presentation 31-Oct-18 1:00pm GMT,Thomson Reuters StreetEvents
Nov-12-18,Edited Transcript of ARQL earnings conference call or presentation 31-Oct-18 1:00pm GMT,Thomson Reuters StreetEvents
Nov-14-18,"ArQule to Present at the 30th Annual Piper Jaffray Healthcare Conference on November 28, 2018",Business Wire
Nov-16-18,ArQule Presents Clinical and Preclinical Data for ARQ 751 at the 30th EORTC/AACR/NCI Symposium,Business Wire
Nov-16-18,Options Traders Expect Huge Moves in ArQule (ARQL) Stock,Zacks
Nov-16-18,"The Daily Biotech Pulse: Mallinckrodt FDA Verdict, European Cheer For Bristol-Myers Squibb, Morphosys Clinches Licensing Deal",Benzinga
Nov-19-18,"ArQule to Present Clinical Data for its BTK Inhibitor, ARQ 531, at the 2018 American Society of Hematology (ASH) Annual Meeting",Business Wire
Nov-21-18,Could ArQule Incs (NASDAQ:ARQL) Investor Composition Influence The Stock Price?,Simply Wall St.
Nov-29-18,"Recent Analysis Shows HudBay Minerals, Meridian Bioscience, ArQule, Mesoblast, Concho Resources, and Liberty Global Market Influences  Renewed Outlook, Key Drivers of Growth",GlobeNewswire
Nov-29-18,"ArQule to Host Analyst Call Highlighting Clinical Progress from Ongoing Phase 1 Study of Reversible BTK Inhibitor, ARQ 531, in Patients with Relapsed/Refractory Hematologic Malignancies",Business Wire
Dec-03-18,"ArQule Announces Clinical Data from Ongoing Phase 1 Study of Reversible BTK Inhibitor, ARQ 531, in Patients with Relapsed/Refractory Hematologic Malignancies at the 2018 ASH Annual Meeting",Business Wire
Dec-12-18,"ArQule, Inc. (ARQL): Are Hedge Funds Right About This Stock?",Insider Monkey
Dec-19-18,ArQule Added to the NASDAQ Biotechnology Index,Business Wire
Dec-24-18,Options Traders Expect Huge Moves in ArQule (ARQL) Stock,Zacks
Dec-26-18,4 Pharma Stocks Heating Up On Wednesday (12/26/18),ACCESSWIRE
Dec-26-18,Biotech News Driving These Companies,ACCESSWIRE
Dec-26-18,"Detailed Research: Economic Perspectives on Canopy Growth, ArQule, MoneyGram International, Teradata, Clovis Oncology, and Axovant Sciences  What Drives Growth in Today's Competitive Landscape",GlobeNewswire
Dec-31-18,Penny Stocks to Buy Using Technical Analysis for January 2019,Investopedia
Jan-07-19,"What You Must Know About ArQule, Inc.s (NASDAQ:ARQL) Beta Value",Simply Wall St.
Jan-09-19,Basilea Announces Positive Interim Results from Registrational Phase 2 Study with Oncology Drug Candidate Derazantinib in Intrahepatic Cholangiocarcinoma (iCCA),Business Wire
Jan-22-19,Penny Stocks to Buy Using Technical Analysis for January 2019,Investopedia
Feb-21-19,"ArQule to Report Fourth Quarter and Full Year 2018 Financial Results on March 7, 2019",Business Wire
Feb-21-19,"ArQule to Present at the 8th Annual Leerink Partners Global Healthcare Conference on February 28, 2019",Business Wire
Feb-25-19,ArQule Announces Publication of Clinical Data with Miransertib in Proteus Syndrome,Business Wire
Feb-26-19,"Factors of Influence in 2019, Key Indicators and Opportunity within Conagra Brands, Pieris Pharmaceuticals, ArQule, MoneyGram International, Internap, and TIM Participacoes S.A  New Research Emphasizes Economic Growth",GlobeNewswire
Mar-06-19,"Is ArQule, Inc.s (NASDAQ:ARQL) CEO Paid At A Competitive Rate?",Simply Wall St.
Mar-07-19,"Why Rosetta Stone, ArQule, and Fly Leasing Jumped Today",Motley Fool
Mar-07-19,Arqule Inc (ARQL) Q4 2018 Earnings Conference Call Transcript,Motley Fool
Mar-07-19,Here's Why ArQule Is Soaring Today,Motley Fool
Mar-07-19,ArQule Reports Fourth Quarter and Full Year 2018 Financial Results,Business Wire
Mar-11-19,"ArQule to Participate in the 31st Annual ROTH Conference on March 17-19, 2019",Business Wire
Mar-13-19,Edited Transcript of ARQL earnings conference call or presentation 7-Mar-19 2:00pm GMT,Thomson Reuters StreetEvents
Mar-13-19,"ArQule to Present at Oppenheimers 29th Annual Healthcare Conference on March 20, 2019",Business Wire
